Validation and evaluation of serological correlates of protection for inactivated enterovirus 71 vaccine in children aged 6-35 months

References

• Kung YA, Hung CT, Liu YC, Shih SR. Update on the development of enterovirus 71 vaccines. Expert Opin Biol Ther 2014; 14:1455-64; PMID:24989170; http://dx.doi.org/10.1517/14712598.2014.935330
   PubMed Web of Science ®Google Scholar
• McMinn PC. Enterovirus vaccines for an emerging cause of brain-stem encephalitis. N Engl J Med 2014; 370:792-4; PMID:24571750; http://dx.doi.org/10.1056/NEJMp1400601
   PubMed Web of Science ®Google Scholar
• Ooi MH, Wong SC, Lewthwaite P, Cardosa MJ, Solomon T. Clinical features, diagnosis, and management of enterovirus 71. Lancet Neurol 2010; 9:1097-105; PMID:20965438; http://dx.doi.org/10.1016/S1474-4422(10)70209-X
   PubMed Web of Science ®Google Scholar
• Solomon T, Lewthwaite P, Perera D, Cardosa MJ, McMinn P, Ooi MH. Virology, epidemiology, pathogenesis, and control of enterovirus 71. Lancet Infect Dis 2010; 10:778-90; PMID:20961813; http://dx.doi.org/10.1016/S1473-3099(10)70194-8
   PubMed Web of Science ®Google Scholar
• Yip CC, Lau SK, Woo PC, Yuen KY. Human enterovirus 71 epidemics: what's next? Emerg Health Threats J 2013; 6:19780; PMID:24119538
   PubMedGoogle Scholar
• Chong P, Liu CC, Chow YH, Chou AH, Klein M. Review of enterovirus 71 vaccines. Clin Infect Dis 2015; 60:797-803; PMID:25352588; http://dx.doi.org/10.1093/cid/ciu852
   PubMed Web of Science ®Google Scholar
• Xing W, Liao Q, Viboud C, Zhang J, Sun J, Wu JT, Chang Z, Liu F, Fang VJ, Zheng Y,et al. Hand, foot, and mouth disease in China, 2008–12: an epidemiological study. Lancet Infect Dis 2014; 14:308-18; PMID:24485991; http://dx.doi.org/10.1016/S1473-3099(13)70342-6
   PubMed Web of Science ®Google Scholar
• McMinn P, Lindsay K, Perera D, Chan HM, Chan KP, Cardosa MJ. Phylogenetic analysis of enterovirus 71 strains isolated during linked epidemics in Malaysia Singapore,and Western Australia. J Virol 2001; 75:7732-8; PMID:11462047; http://dx.doi.org/10.1128/JVI.75.16.7732-7738.2001
   PubMed Web of Science ®Google Scholar
• Lee MS, Chang LY. Development of enterovirus 71 vaccines. Expert Rev Vaccines 2010; 9:149-56; PMID:20109026; http://dx.doi.org/10.1586/erv.09.152
   PubMed Web of Science ®Google Scholar
• Zhu FC, Meng FY, Li JX, Li XL, Mao QY, Tao H, Zhang YT, Yao X, Chu K, Chen QH,et al. Efficacy, safety, and immunology of an inactivated alum-adjuvant enterovirus 71 vaccine in children in China: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial. Lancet 2013; 381:2024-32; PMID:23726161; http://dx.doi.org/10.1016/S0140-6736(13)61049-1
   PubMed Web of Science ®Google Scholar
• Li R, Liu L, Mo Z, Wang X, Xia J, Liang Z, Zhang Y, Li Y, Mao Q, Wang J, et al. An inactivated enterovirus 71 vaccine in healthy children. N Engl J Med 2014; 370:829-37; PMID:24571755; http://dx.doi.org/10.1056/NEJMoa1303224
   PubMed Web of Science ®Google Scholar
• Zhu F, Xu W, Xia J, Liang Z, Liu Y, Zhang X, Tan X, Wang L, Mao Q, Wu J, et al. Efficacy, safety, and immunogenicity of an enterovirus 71 vaccine in China. N Engl J Med 2014; 370:818-28; PMID:24571754; http://dx.doi.org/10.1056/NEJMoa1304923
   PubMed Web of Science ®Google Scholar
• Prentice RL. Surrogate endpoints in clinical trials: definition and operational criteria. Stat Med 1989; 8:431-40; PMID:2727467; http://dx.doi.org/10.1002/sim.4780080407
   PubMed Web of Science ®Google Scholar
• Qin L, Gilbert PB, Corey L, McElrath MJ, Self SG. A framework for assessing immunological correlates of protection in vaccine. J Infect Dis 2007; 196:1304-12; PMID:17922394; http://dx.doi.org/10.1086/522428
   PubMed Web of Science ®Google Scholar
• Golber PB, Qin L, Self SG. Evaluating a surrogate endpoint at three levels, with application to vaccine. Stat Med 2008; 27:4758-78; PMID:17979212; http://dx.doi.org/10.1002/sim.3122
   PubMed Web of Science ®Google Scholar
• Kohberger RC, Jemiolo D, Noriega F. Prediction of pertussis vaccine efficacy using a correlates of protection model. Vaccine 2008; 26:3516-21; PMID:18495303; http://dx.doi.org/10.1016/j.vaccine.2008.04.016
   PubMed Web of Science ®Google Scholar
• Plotkin SA, Gilbert PB. Nomenclature for Immune Correlates of Protection After Vaccination. Clinical Infectious Disease 2012; 54:1615-7; http://dx.doi.org/10.1093/cid/cis238
   PubMed Web of Science ®Google Scholar
• Dunning AJ. A model for immunological correlates of protection. Stat Med 2006; 25:1485-97; PMID:16158409; http://dx.doi.org/10.1002/sim.2282
   PubMed Web of Science ®Google Scholar
• Sadoff JC, Wittes J. Correlates, surrogates, and vaccines. J Infect Dis 2007; 196:1279-81; PMID:17922389; http://dx.doi.org/10.1086/522432
   PubMed Web of Science ®Google Scholar
• Djomo PN, Thomas SL, Fine PEM. Correlates of vaccine-induced protection: methods and implications. World Health Organization 2013:1-49. http://www.who.int/vaccines-documents/
   Google Scholar
• Nauta J. Statistics in clinical vaccine trials. Vol. 8, Correlates of Protection. Heidelberg (Berlin): Springer; 2011. 107p.
   Google Scholar
• Gilbert PB, Gabriel EE, Miao XP, Li XM, Su SC, Parrino J, Chan IS. Fold rise in antibody titers by measured by glycoprotein-based enzyme-linked immunosorbent assay is an excellent correlate of protection for a herpes zoster vaccine, demonstrated via the vaccine efficacy curve. J Infect Dis 2014; 210:1573-81; PMID:24823623; http://dx.doi.org/10.1093/infdis/jiu279
   PubMed Web of Science ®Google Scholar
• Wu CN, Lin YC, Fann C, Liao NS, Shih SR, Ho MS. Protection against lethal enterovirus 71 infection in newborn mice by passive immunization with subunit VP1 vaccines and inactivated virus. Vaccine 2001; 20:895-904; PMID:11738755; http://dx.doi.org/10.1016/S0264-410X(01)00385-1
   PubMed Web of Science ®Google Scholar
• Foo DG, Alonso S, Chow VT, Poh CL. Passive protection against lethal enterovirus 71 infection in newborn mice by neutralizing antibodies elicited by a synthetic peptide. Microbes Infect 2007; 9:1299-306; PMID:17890123; http://dx.doi.org/10.1016/j.micinf.2007.06.002
   PubMed Web of Science ®Google Scholar
• Chang LY, King CC, Hsu KH, Ning HC, Tsao KC, Li CC, Huang YC, Shih SR, Chiou ST, Chen PY, et al. Risk factors of enterovirus 71 infection and associated hand, foot, and mouth disease/herpangina in children during an epidemic in Taiwan. Pediatrics 2002; 109:e88; PMID:12042582; http://dx.doi.org/10.1542/peds.109.6.e88
   PubMed Web of Science ®Google Scholar
• Wang SM, Liu CC. Update of enterovirus 71 infection: epidemiology, pathogenesis and vaccine. Expert Rev Anti Infect Ther 2014; 12:447-56; PMID:24579906; http://dx.doi.org/10.1586/14787210.2014.895666
   PubMed Web of Science ®Google Scholar
• Cox RJ. Correlates of protection to influenza virus, where do we go from here?. Hum Vaccin Immunother 2013; 9:405-8; PMID:23291930; http://dx.doi.org/10.4161/hv.22908
   PubMed Web of Science ®Google Scholar
• Chen YJ, Meng FY, Mao Q, Li JX, Wang H, Liang ZL, Zhang YT, Gao F, Chen QH, Hu Y, et al. Clinical evaluation for batch consistency of an inactivated enterovirus 71 vaccine in a large-scale phase 3 clinical trial. Hum Vaccin Immunother 2014; 10:1366-72; PMID:24633366; http://dx.doi.org/10.4161/hv.28397
   PubMed Web of Science ®Google Scholar
• Black S, Nicolay U, Vesikari T, Knuf M, Del Giudice G, Della Cioppa G, Tsai T, Clemens R, Rappuoli R. Hemagglutination inhibition antibody titers as a correlate of protection for inactivated influenza vaccines in children. Pediatr Infect Dis J 2011; 30:1081-5; PMID:21983214; http://dx.doi.org/10.1097/INF.0b013e318236-7662
   PubMed Web of Science ®Google Scholar
• Siber GR, Chang I, Baker S, Fernsten P, O'Brien KL, Santosham M, Klugman KP, Madhi SA, Paradiso P, Kohberger R. Estimating the protective concentration of anti-pneumococcal capsular polysccharide antibodies. Vaccine 2007; 25:3816-26; PMID:17368878; http://dx.doi.org/10.1016/j.vaccine.2007.01.119
   PubMed Web of Science ®Google Scholar
• Liang Z, Mao Q, Gao Q, Li X, Dong C, Yu X, Yao X, Li F, Yin W, Li Q, et al. Establishing China's national standards of antigen content and neutralizing antibody responses for evaluation of enterovirus 71 (EV71) vaccines. Vaccine 2011; 29:9668-74; PMID:22015395; http://dx.doi.org/10.1016/j.vaccine.2011.10.018
   PubMed Web of Science ®Google Scholar
• World Health Organization. Manual for the virological investigation of poliomyelitis World Health Organization 1997. http://WHO/EPI/CD5/POLIO/90.1.
   Google Scholar